Об авторах
Васина Любовь ВасильевнаФГБУ «Северо-Западный федеральный медицинский исследовательский центр им. В.А. Алмазова» Минздрава РФ 197341, Санкт-Петербург д-р мед. наук, ст. науч. сотр. лаб. микроциркуляции lubov.vasina@gmail.com
Список литературы
Paredes R.M., Etzler J.C., Watts L.T., Zheng W., Lechleiter J.D. Chemical calcium indicators. Methods. 2008; 46(3): 143-51.
Nesbitt W.S., Harper I.S., Schoenwaelder S.M., Yuan Y., Jackson S.P. A live cell micro-imaging technique to examine platelet calcium signaling dynamics under blood flow. Methods Mol. Biol. 2012; 788: 73-89.
Merritt J.E., McCarthy S.A., Davies M.P., Moores K.E. Use of fluo-3 to measure cytosolic Ca2+ in platelets and neutrophils. Biochem. J. 1990; 269(2): 513-9.
Do Céu Monteiro M., Sansonetty F., Gonçalves M.J., O’Connor J.E. Flow cytometric kinetic assay of calcium mobilization in whole blood platelets using Fluo-3 and CD 41. Cytometry. 1999; 35(4): 302-10.
Wave J.A., Smith M., Salzman E.W. Synergism of plateletaggregating agents. Role of elevation of cytoplasmic calcium. J. Clin. Invest. 1987; 80(1): 267-71.
Shen Z.Q., Chen Z.H., Ma G.Y., Wang D.C., Wu W.L., Liu W.P. et al. Inhibitory effects of copper-aspirin complex on platelet aggregation. Acta Pharmacol. Sin. 1997; 18(4): 358-62.
Shen Z.Q., Li L., Wu L.O., Chen Z.H., Liu W.P. Effects of copperaspirin complex on plasma prostaglandin F1α level and platelet cytosolic calcium in rabbits. Platelets. 1999; 10(5): 345-8.
Hecker M., Brüne B., Decker K., Ullrich V. The sulfhydryl reagent thimerosal elicits human platelet aggregation by mobilization of intracellular calcium and secondary prostaglandin endoperoxide formation. Biochem. Biophys. Res. Commun. 1989; 159(3): 961-8.
Holinstat M., Voss B., Bilodeau M.L., McLaughlin J.N., Cleator J., Hamm H.E. PAR 4, but not PAR 1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation. J. Biol. Chem. 2006; 281(36): 26665-74.
Holinstat M., Voss B., Bilodeau M.L., Hamm H.E. Protease-activated receptors differentially regulate human platelet activation through a phosphatidic acid-dependent pathway. Mol. Pharmacol. 2007; 71(3): 686-94.
Wallace J.L., McKnight W., Del Soldato P., Baydoun A.R., Cirino G. Anti-thrombotic effects of a nitric oxide — releasing, gastric-sparing aspirin derivative. J. Clin. Invest. 1995; 96(6): 2711-8.